Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
210 E 64th St
Fl 3
New York, NY 10065Phone+1 212-434-4460Fax+1 212-434-4489
Education & Training
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2014 - 2017
- NYIT College Of Osteopathic MedicineClass of 2014
Certifications & Licensure
- FL State License 2022 - Present
- NY State License 2018 - 2025
- VA State License 2014 - 2018
- DC State License 2014 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions Start of enrollment: 2019 Jun 28
Roles: Contact
- Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment of Advanced Uveal Melanoma Start of enrollment: 2023 Jan 13
Roles: Contact
Publications & Presentations
PubMed
- Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 2023.Rino S Seedor, Andrew E Aplin, Corine Bertolotto, Richard D Carvajal, Nigel Deacon
Pigment Cell & Melanoma Research. 2024-10-09 - 3 citationsMinimally Invasive Treatment Options for Hepatic Uveal Melanoma Metastases.Abin Sajan, Samuel Fordyce, Andrew Sideris, Connie Liou, Zeeshan Toor
Diagnostics. 2023-05-24 - 18 citationsMultimodal single-cell and whole-genome sequencing of small, frozen clinical specimens.Yiping Wang, Joy Linyue Fan, Johannes C Melms, Amit Dipak Amin, Yohanna Georgis
Nature Genetics. 2023-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: